BayMark Health Services is North America’s largest provider of medication-assisted treatment (MAT) for substance use disorders, helping thousands of individuals on their path to recovery every day. Their service offerings include opioid treatment programs (OTP), office-based opioid treatment (OBOT) practices, outpatient and inpatient detox services, residential treatment centers, and behavioral health services. Founded in 2015, BayMark Health Services operates in the Health Care industry and is headquartered in the United States. The company aims to help as many individuals as possible in need of substance use and mental health disorders, making it an interesting prospect for potential investors seeking opportunities in the ever-growing healthcare sector. Although specific investment details are not available at the moment, BayMark Health Services presents a compelling opportunity for venture capitalists looking to support and capitalize on innovative solutions addressing critical public health challenges.
There is no investment information
No recent news or press coverage available for BayMark Health Services.